Plain-English translation of NCT07069647 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a computer software tool called VeriSee can help doctors catch vision-threatening eye diseases earlier. The software analyzes eye photos to detect diabetic retinopathy (damage to the eye from diabetes) and age-related macular degeneration (vision loss in older adults). Half of participants will receive results on the same day using AI assistance, while the other half will follow the standard process of waiting for a follow-up appointment.
Many people develop serious eye problems from diabetes or aging but are diagnosed too late because family medicine doctors don't have good screening tools. This trial wants to see if AI can help catch these diseases earlier so vision can be preserved and patients avoid becoming severely impaired.
You likely qualify if…
You likely don't qualify if…
You will have a photograph taken of the back of your eye (fundus photography). If you are randomly assigned to the AI group, a computer will analyze your photo and you'll receive your results that same day with explanation from a doctor. If you're in the standard care group, you'll schedule a follow-up appointment to get your results and have your doctor review them with you. Either way, if any problems are found, you'll be referred to an eye specialist for further evaluation.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Taiwan